Literature DB >> 28448853

A cluster of aspartic residues in the extracellular loop II of PAR 4 is important for thrombin interaction and activation of platelets.

Daniel Sánchez Centellas1, Sushanth Gudlur1, Alejandro Vicente-Carrillo1, Sofia Ramström1, Tomas L Lindahl2.   

Abstract

Thrombin activates platelets via proteolytic cleavage of protease-activated receptors (PARs) 1 and 4. The two PARs have distinct but complementary roles. The mechanisms responsible for PAR1 activation by thrombin have been extensively studied. However, much less is known regarding thrombin activation of PAR4, especially the potential involvement of regions of PAR4 other than the N-terminal, which is bound to the catalytic site of thrombin. We have studied PAR4 in S. cerevisiae strain MMY12, an expression system in which the GPCR receptors are connected to a Lac Z reporter gene resulting in increased β-galactosidase activity. This approach was used to assess PAR4 mutants to evaluate the contribution of different aspartic residues in facilitating PAR4 activation. Furthermore, peptides mimicking parts of the PAR4 N-terminal and the second extracellular loop (ECLII) were tested for their ability to inhibit platelet activation by thrombin. Binding of these peptides to γ-thrombin was studied by monitoring the decrease in tryptophan fluorescence intensity of thrombin. We conclude that not only the N-terminal but also the electronegative aspartic residues D224, D230 and D235 (located in ECLII) are be important for PAR4 binding to thrombin. We further suggest that they play a role for the tethered ligand binding to the receptor, as mutations also affected activation in response to a PAR4-activating peptide mimicking the new N-terminal formed after cleavage. This agrees with previous results on PAR1 and thrombin binding. We suggest that the ECLII of PAR4 could be a potential target for antithrombotic drug development.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28448853     DOI: 10.1016/j.thromres.2017.04.006

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Acetylcholine Inhibits Platelet Activation.

Authors:  John A Bennett; Sara K Ture; Rachel A Schmidt; Michael A Mastrangelo; Scott J Cameron; Lara E Terry; David I Yule; Craig N Morrell; Charles J Lowenstein
Journal:  J Pharmacol Exp Ther       Date:  2019-02-14       Impact factor: 4.030

2.  Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).

Authors:  Pierre E Thibeault; Jordan C LeSarge; D'Arcy Arends; Michaela Fernandes; Peter Chidiac; Peter B Stathopulos; Leonard G Luyt; Rithwik Ramachandran
Journal:  J Biol Chem       Date:  2019-12-31       Impact factor: 5.157

3.  PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153.

Authors:  Xu Han; Lukas Hofmann; Maria de la Fuente; Nathan Alexander; Krzysztof Palczewski; Marvin T Nieman
Journal:  Blood       Date:  2020-11-05       Impact factor: 25.476

Review 4.  Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.

Authors:  Gamariel Rwibasira Rudinga; Ghulam Jilany Khan; Yi Kong
Journal:  Int J Mol Sci       Date:  2018-02-14       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.